» Articles » PMID: 14499340

Mechanisms of Regulation of the Expression and Function of G Protein-coupled Receptor Kinases

Overview
Journal Cell Signal
Date 2003 Sep 23
PMID 14499340
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

G protein-coupled receptor kinases (GRKs) are key modulators of G protein-coupled receptor signalling. Increasing evidence points to the occurrence of complex mechanisms able to modulate the subcellular localization, activity and expression levels of GRKs, revealing new functional interactions of these kinases with different cellular proteins and transduction cascades. GRK activity and subcellular targeting is tightly regulated by interaction with receptor domains, G protein subunits, lipids, anchoring proteins, caveolin and calcium-sensing proteins. In addition, GRK phosphorylation by several other kinases has recently been shown to modulate its functionality, thus putting forward new feedback mechanisms connecting different signalling pathways to G protein-coupled receptors (GPCR) regulation. On the other hand, the mechanisms governing GRK expression at both transcriptional and protein stability levels are just beginning to be unveiled. Namely, GRK2 has been shown to be rapidly degraded by the proteasome pathway in a process dependent on beta-arrestin and c-Src function, and also to be proteolyzed by m-calpain. A better knowledge of GRK regulatory mechanisms would contribute to greater understanding of GRK physiological function and also its reported alterations in different pathological situations, such as congestive heart failure, hypertension or inflammation.

Citing Articles

GRK2 and Mitochondrial Dynamics in Cardiovascular Health and Disease.

Gatto C, Rusciano M, Visco V, Ciccarelli M Int J Mol Sci. 2025; 26(5).

PMID: 40076919 PMC: 11900936. DOI: 10.3390/ijms26052299.


Interleukin-33: A Double-Edged Sword in Sepsis.

Liu S, Yue Y, Wu Q, Zhang L Transl Perioper Pain Med. 2025; 11(2):612-619.

PMID: 39991638 PMC: 11845250. DOI: 10.31480/2330-4871/188.


Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure.

Parichatikanond W, Duangrat R, Kurose H, Mangmool S Cells. 2024; 13(20.

PMID: 39451192 PMC: 11506672. DOI: 10.3390/cells13201674.


The β-adrenergic biased agonist nebivolol inhibits the development of Th17 and the response of memory Th17 cells in an NF-κB-dependent manner.

Hajiaghayi M, Gholizadeh F, Han E, Little S, Rahbari N, Ardila I Front Immunol. 2024; 15:1446424.

PMID: 39445009 PMC: 11496295. DOI: 10.3389/fimmu.2024.1446424.


Uncovering conserved networks and global conformational changes in G protein-coupled receptor kinases.

Seo M, Yu W Comput Struct Biotechnol J. 2024; 23:3445-3453.

PMID: 39403406 PMC: 11472376. DOI: 10.1016/j.csbj.2024.09.014.